TITLE

Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study

AUTHOR(S)
Thakur, C.P.; Kumar, M.; Kumar, P.; Mishra, B.N.; Pandey, A.K.
PUB. DATE
June 1988
SOURCE
British Medical Journal (Clinical Research Edition);6/4/1988, Vol. 296 Issue 6636, p1557
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Evaluates the efficacy and safety of regimens for kala-azar with sodium stibogluconate treatment of patients in India. Number of patients with temperature returning to normal at the end of regimen treatment; Implication on the logistics regression of cured patients; Conclusion on sodium stibogluconate administration.
ACCESSION #
4931551

 

Related Articles

  • Comparison of regimens of treatment with sodium stibogluconate in kala-azar. Thakur, C.P.; Kumar, Mahendra; Singh, Satis Kumar; Sharma, Dilip; Prasad, Uma Shanker; Singh, Rama Shray Prasad; Dhawan, P.S.; Achari, Vijay // British Medical Journal (Clinical Research Edition);3/24/1984, Vol. 288 Issue 6421, p895 

    Investigates the regimen of treatment for kala-azar with sodium stibogluconate in Bihar, India. Treatment of 126 kala-azar infected patients; Similarity of symptomatic outcomes; Diagnosis of minor side effects.

  • Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral... Moore, Elinore; O'Flaherty, Deidre; Heuvelmans, Hans; Seaman, Jill; Veeken, Hans; de Wit, Sjoukje; Davidson, Robert N. // Bulletin of the World Health Organization;2001, Vol. 79 Issue 5, p388 

    Objective To compare the use of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis (kala-azar). Methods A total of 102 patients with confirmed kala-azar were treated in a mission hospital in West Pokot region, Kenya, with sodium stibogluconate (20...

  • Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial. Musa, Ahmed; Khalil, Eltahir; Hailu, Asrat; Olobo, Joseph; Balasegaram, Manica; Omollo, Raymond; Edwards, Tansy; Rashid, Juma; Mbui, Jane; Musa, Brima; Abuzaid, Abuzaid Abdalla; Ahmed, Osama; Fadlalla, Ahmed; El-Hassan, Ahmed; Mueller, Marius; Njoroge, Simon; Mucee, Geoffrey; Manduku, Veronica; Mutuma, Geoffrey; Apadet, Lilian // PLoS Neglected Tropical Diseases;Jun2012, Vol. 6 Issue 6, p1 

    Background: Alternative treatments for visceral leishmaniasis (VL) are required in East Africa. Paromomycin sulphate (PM) has been shown to be efficacious for VL treatment in India. Methods: A multi-centre randomized-controlled trial (RCT) to compare efficacy and safety of PM (20 mg/kg/day for...

  • Major Four-year Project Launched to Treat Kala-Azar.  // India -- West;1/27/2012, Vol. 37 Issue 10, pA30 

    The article reports on the kala-azar, a comprehensive four-year project, launched by an international consortium for diagnosis and treatment of visceral leishmaniasis in India and Bangladesh.

  • Evidence that the High Incidence of Treatment Failures in Indian Kala-Azar Is Due to the Emergence of Antimony-Resistant Strains of Leishmania donovani. Lira, Rosalia; Sundar, Shyam; Makharia, A.; Kenney, Richard; Gam, Albert; Saraiva, Elvira; Sacks, David // Journal of Infectious Diseases;8/1/99, Vol. 180 Issue 2 

    Investigates the treatment failures in Kala-Azar infection due to antimony-resistant strains of Leishmania donovani in India. Characterization of kala-azar; Use of splenic aspirates as a source material for the culture of promastigote; Susceptibility of intracellular amastigotes to sodium...

  • Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India. Ramesh, V.; Singh, Ruchi; Avishek, Kumar; Verma, Aditya; Deep, Deepak Kumar; Verma, Sandeep; Salotra, Poonam // PLoS Neglected Tropical Diseases;12/7/2015, Vol. 9 Issue 12, p1 

    A correction to the article "Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India," by V. Ramesh and colleagues is presented.

  • Gold treatment for kala-azar. Singh, M.P.; Mishra, M.; Khan, A.B.; Ramdas, S.L.; Panjiyar, S. // BMJ: British Medical Journal (International Edition);11/25/89, Vol. 299 Issue 6711, p1318 

    Investigates the use of gold treatment for patients with kala-azar. Enlargement of the liver; Occurrence of leishmania; Toxicity of the gold treatment.

  • Shave Excision as an Adjunct to the Therapy of a Rhinophyma-like Complication in Post-kala-azar Dermal Leishmaniasis. Ramesh, V.; Misra, R.S; Khunger, Niti; Beena, K.R; Salotra, Poonam; Mukherjee, A. // Acta Dermato-Venereologica;6/23/99, Vol. 79 Issue 4, p330 

    Examines the mode on the treatment of rhinophyma-like complication for post-kala-azar dermal leishmaniasis in India. Presence of transient erythema on the nose and cheeks; Prominence of facial erythematous indurations; Effectivity of sodium antimony gluconate.

  • Treatment of Mediterranean visceral leishmaniasis. Gradoni, L.; Bryceson, A. // Bulletin of the World Health Organization;1995, Vol. 73 Issue 2, p191 

    Examines therapeutic approaches for zoonotic visceral leishmaniasis (ZVL) in nine Mediterranean countries. Drug regiments adopted in the management of ZVL patients in each country; Greece; Morocco; Italy; Malta; Portugal; Spain; Tunisia; Algeria; France.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics